Evaluation of efficacy and comparative frequency of adverse events in patients with ulcerative colitis receiving the original infliximab and its biosimilar. One year of observation
Knyazev, O V, Shkurko, T V, Kagramanova, A V, Lishchinskaya, A A, Zvyaglova, M Yu, Korneeva, I A, Babayan, A F, Parfenov, A I
Published in Terapevtic̆eskii arhiv (15.08.2019)
Published in Terapevtic̆eskii arhiv (15.08.2019)
Get full text
Journal Article
Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn's disease when switching from the original infliximab to its biosimilars
Knyazev, O V, Zvyaglova, M Y, Kagramanova, A V, Li, I A, Sabelnikova, E A, Lishchinskaya, A A, Kulakov, D S, Parfenov, A I
Published in Terapevtic̆eskii arhiv (15.02.2021)
Published in Terapevtic̆eskii arhiv (15.02.2021)
Get full text
Journal Article
Efficacy and safety of tofacitinib in moderate and severe ulcerative colitis in real clinical practice: three years of observation
Knyazev, O. V., Kagramanova, A. V., Lishchinskaya, A. A., Li, I. A., Podolskaya, D. V., Shkurko, T. V., Nanaeva, B. A., Aleksandrov, T. L., Baranova, T. A., Tishaeva, I. A., Zvyaglova, M. Yu, Parfenov, A. I.
Published in Medicinskij sovet (19.10.2021)
Published in Medicinskij sovet (19.10.2021)
Get full text
Journal Article